Research has demonstrated that mutations in the amyloid protein precursor (APP) and presenilin-1/2 (PS 1/2) genes lead to abnormal production of Aβ, which is strongly linked to the development of early onset Alzheimer’s disease (AD) [6, 7]. The gene discussed is APP; the disease is Alzheimer disease.